Ly6Clo monocytes drive immunosuppression and confer resistance to anti-VEGFR2 cancer therapy

Overview of attention for article published in Journal of Clinical Investigation, July 2017

Altmetric Badge

About this Attention Score

In the top 5% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (95th percentile)
Good Attention Score compared to outputs of the same age and source (78th percentile)

So far, Altmetric has seen 20 tweets from 19 users, with an upper bound of 185,387 followers.

Create an immunosuppressive microenvironment .. with nonclassical Ly6Clo monocytes .. | colorectal cancer via @harvardmed https://t.co/S1jkECfeXs https://t.co/IPXqyFmP7G

RT @jclinicalinvest: Nonclassical Ly6Clo monocytes create an immunosuppressive microenvironment and mediate resistance to anti-VEGFR2 treat…

RT @jclinicalinvest: Nonclassical Ly6Clo monocytes create an immunosuppressive microenvironment and mediate resistance to anti-VEGFR2 treat…

Nonclassical Ly6Clo monocytes create an immunosuppressive microenvironment and mediate resistance to anti-VEGFR2 treatment in colorectal cancer @harvardmed https://t.co/vDuqB5UN3t https://t.co/oVjSCtKBDs

This page shows the most recent tweets that mention this research output.

Click here to find out how to access more activity, including 16 additional tweets.